Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume
- PMID: 1057909
- DOI: 10.1111/j.1445-5994.1975.tb03249.x
Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume
Abstract
The effect on blood pressure of high (400 mg/day-S400) and moderate dose (200 mg/day-S200) spironolactone and chlorthalidone (100 mg/day-C100), given in a random double-blind manner was related to plasma renin activity and plasma volume in 38 essential hypertensives. The fall in pressure from a control of 154/103 mm Hg was essentially the same after four weeks of each drug--S400 deltaBP 24/13 mm, S200 18/9 mm, C100 17/12 mm (all P less than 0-001). Twelve of 37 patients (32%) had low initial renin, but this appeared as responsive to the chlorthalidone stimulus as that of the normal renin group. The antihypertensive effect of all regimens was unrelated to plasma renin activity. Plasma volume was significantly lowered at the end of each treatment period, but the decline could not be correlated with blood pressure effects. Patients with initially low plasma volume were more likely to respond to S400 (r = 0-545, P less than 0-001), whereas the antihypertensive effect of the S200 and C100 regimens was independent of this variable.
Similar articles
-
Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.Am J Cardiol. 1973 Sep 20;32(4):523-32. doi: 10.1016/s0002-9149(73)80044-x. Am J Cardiol. 1973. PMID: 4729722 No abstract available.
-
Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension.Am J Cardiol. 1975 Oct 31;36(5):716-21. doi: 10.1016/0002-9149(75)90174-5. Am J Cardiol. 1975. PMID: 1103606 Clinical Trial.
-
Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.Can Med Assoc J. 1983 Jan 1;128(1):31-4. Can Med Assoc J. 1983. PMID: 6336600 Free PMC article. Clinical Trial.
-
[Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].Schweiz Med Wochenschr. 1977 Jan 29;107(4):104-15. Schweiz Med Wochenschr. 1977. PMID: 834983 Clinical Trial. German.
-
[Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].Dtsch Med Wochenschr. 1975 Mar 21;100(12):577-84. doi: 10.1055/s-0028-1106260. Dtsch Med Wochenschr. 1975. PMID: 1168122 German.
Cited by
-
Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis.J Hum Hypertens. 2024 May;38(5):383-392. doi: 10.1038/s41371-023-00891-1. Epub 2024 Jan 11. J Hum Hypertens. 2024. PMID: 38200100 Free PMC article.
-
ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism.Hypertension. 2025 Jun;82(6):1046-1055. doi: 10.1161/HYPERTENSIONAHA.125.24711. Epub 2025 Mar 31. Hypertension. 2025. PMID: 40160086
-
Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.Br Med J. 1976 Jan 31;1(6004):251-4. doi: 10.1136/bmj.1.6004.251. Br Med J. 1976. PMID: 764929 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources